10-year trend analysis of atrioventricular node ablation in patient with atrial fibrillation: 2005–2014 United State hospitalization
Abstract Introduction Atrial fibrillation (AF) ablation and Atrioventricular Node (AVN) ablation are both important non-pharmacological therapy of AF. In spite of increased availability of AF ablation data, that of AVN ablation per se is limited. Method AF ablation was identified using ICD-9 procedu...
Gespeichert in:
Veröffentlicht in: | European heart journal 2020-11, Vol.41 (Supplement_2) |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Abstract
Introduction
Atrial fibrillation (AF) ablation and Atrioventricular Node (AVN) ablation are both important non-pharmacological therapy of AF. In spite of increased availability of AF ablation data, that of AVN ablation per se is limited.
Method
AF ablation was identified using ICD-9 procedure code with principle diagnosis of AF from United States National Inpatient Sample database 2005–2014. From procedure and diagnosis codes of pacemaker insertion followed by ablation, the cohort who underwent AVN ablation was identified. Patients hospitalization with any diagnosis of other type of arrythmia or epicardial ablation were excluded. Complications were defined as per the Agency for Health Care Research and Quality guideline.
Results
Total AF ablation was noted to increase from 2005- 2011, and declined steadily from 2011–2014. In contrast, the number of AVN ablations increased from 4505 cases to 5175 (Figure 1). AVN ablation were mainly performed in elderly patient (mean age 72), and increasingly in patient with higher Charlson Commobidity index (0.9 to 1.7)and higher CHA2DS2-VASc score (2.8 to 3.7) (Table 1). An increasing trend in procedure complications but no significant change in mortalitywere observed with AVN ablation. Progressive increase in the length of stay and the hospitalization cost were also observed over the years with AVN ablation.
Conclusion
AVN ablation is being performed at a steady volume, and increasingly in patients with multiple comorbidities. This trend although was not associated with increased mortality, it was associated with increased hospital complications.
Table 1. Baseline characteristics and outcomes of AVN ablation 2005–2014
Variable
Year
Trend p value
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
AF ablation
9898
10078
11384
17611
14468
14526
19349
18330
16864
11735
0.004
AVN ablation
4505
6309
5438
6144
6628
5561
6505
6545
6169
5175
0.007
Mean age, years
72.05
72.63
72.54
72.26
72.32
72.40
72.64
72.67
72.67
72.87
0.128
Female, %
54.8
54.5
53.2
54.5
53.3
55.1
53.7
53.8
55.6
57.3
0.585
Mean Charlson index
0.90
1.02
1.17
1.22
1.30
1.37
1.32
1.47
1.54
1.69 |
---|---|
ISSN: | 0195-668X 1522-9645 |
DOI: | 10.1093/ehjci/ehaa946.0549 |